BioengineeringbioRxivPreprint
Rational engineering of sdAb-based CAR T cells targeting BCMA enhances antitumor efficacy and persistence in Multiple Myeloma
Vianca Ibarra-Garcia, María Eréndira Calleja-Cervantes, Federica Rochira…·Felipe Prósper
This study engineers sdAb-based CAR T cells targeting BCMA, showing improved antitumor efficacy and persistence in multiple myeloma compared to existing therapies.